By Mustapha Yauri  Dr Sani Aliyu the Director-General National Agency for the Control of AIDS (NACA) says the world has made significant progress on HIV vaccine research and it is inching closer to licensable HIV vaccines.  The director-general made this known at news conference as part of activities to commemorate the 2017 World HIV Vaccine Advocacy Day on Thursday in Abuja.  Aliyu said the world has made significant progress in HIV vaccine research over the last 30 years when HIV was…

By Mustapha Yauri Dr Sani Aliyu the Director-General National Agency for the Control of AIDS (NACA) says the world has made significant progress on HIV vaccine research and it is inching closer to licensable HIV vaccines. The director-general made this known at news conference as part of activities to commemorate the 2017 World HIV Vaccine Advocacy Day on Thursday in Abuja. Aliyu said the world has made significant progress in HIV vaccine research over the last 30 years when HIV was…

Reanalysis of Old HIV Vaccine Trials Finds Researchers Did Not Recognize Potentially Protective Immune Response

Reanalysis of Old HIV Vaccine Trials Finds Researchers Did Not Recognize Potentially Protective Immune Response

Researcher who spiked rabbit blood to fake HIV vaccine results slapped with rare prison sentence

Researcher who spiked rabbit blood to fake HIV vaccine results slapped with rare prison sentence

Rosa Rubicondior: Integrity - The Difference Between Science & Religion

Some people contract HIV and never get sick. These people are called “controllers,” and studying them has long been a focus for researchers seeking a cure for the disease.  Now, an ambitious plan called The Immunity Project has released a white paper outlining how they plan to create an HIV vaccine—free for the entire world population—based on the computerized analysis of blood from HIV controllers.

Is an AIDS Cure Hiding in the Blood of 'Elite Controllers?'

Some people contract HIV and never get sick. These people are called “controllers,” and studying them has long been a focus for researchers seeking a cure for the disease. Now, an ambitious plan called The Immunity Project has released a white paper outlining how they plan to create an HIV vaccine—free for the entire world population—based on the computerized analysis of blood from HIV controllers.

In many ways, the domestic and global fight against HIV/AIDs has made great strides. Yet there are still millions of people who are newly diagnosed with HIV globally each year. One preventive strategy receiving renewed attention and progress is an HIV vaccine. Dr. Larry Corey, the principal investigator of the HIV Vaccine Trials Network based …

In many ways, the domestic and global fight against HIV/AIDs has made great strides. Yet there are still millions of people who are newly diagnosed with HIV globally each year. One preventive strategy receiving renewed attention and progress is an HIV vaccine. Dr. Larry Corey, the principal investigator of the HIV Vaccine Trials Network based …

Are We Really ‘Close’ to an HIV Vaccine?

Are We Really ‘Close’ to an HIV Vaccine?

HIV vaccine

HIV vaccine

New HIV vaccine completely protected against virus in half of monkeys

New HIV vaccine completely protected against virus in half of monkeys

Positive results of trials in monkeys triggered the pharmaceutical company to begin trials in humans, according to researchers at Beth Israel Deaconess Medical Center, Boston.

NIAID has a long-standing commitment to conduct Lyme disease research with the major goals of developing better means of diagnosing, treating, and preventing the disease. To accomplish these objectives, the NIAID Lyme disease research portfolio includes a broad range of activities designed to increase our understanding of this disease.

NIAID has a long-standing commitment to conduct Lyme disease research with the major goals of developing better means of diagnosing, treating, and preventing the disease. To accomplish these objectives, the NIAID Lyme disease research portfolio includes a broad range of activities designed to increase our understanding of this disease.

A Promising HIV Vaccine in South Africa After encouraging early results from a small study, clinical trials will begin in January.

A Promising HIV Vaccine in South Africa

A Promising HIV Vaccine in South Africa After encouraging early results from a small study, clinical trials will begin in January.

Pinterest
Search